Similar articles

• Cigarette smoking and bronchoalveolar T cell populations in sarcoidosis.

  Lawrence EC, Fox TB, Teague RB, Bloom K, Wilson RK. Lawrence EC, et al. Ann N Y Acad Sci. 1986;465:657-64. doi: 10.1111/j.1749-6632.1986.tb18542.x. Ann N Y Acad Sci. 1986. PMID: 2942080 No abstract available.
• [Correlation among gallium-67 scintigraphy, broncho-alveolar lavage, and pathological changes of the lung in patients with pulmonary sarcoidosis].

  Abe S, Nishimura M, Munakata M, Nakano I, Tsuneta Y, Terai T, Ohsaki Y. Abe S, et al. Nihon Kyobu Shikkan Gakkai Zasshi. 1983 Apr;21(4):327-33. Nihon Kyobu Shikkan Gakkai Zasshi. 1983. PMID: 6580477 Japanese. No abstract available.
• Heterogeneity of bronchoalveolar lavage cellularity in stage III pulmonary sarcoidosis.

  Cantin A, Bégin R, Rola-Pleszczynski M, Boileau R. Cantin A, et al. Chest. 1983 Mar;83(3):485-6. doi: 10.1378/chest.83.3.485. Chest. 1983. PMID: 6825482
• NIH conference. Pulmonary sarcoidosis: a disease characterized and perpetuated by activated lung T-lymphocytes.

  [No authors listed] [No authors listed] Ann Intern Med. 1981 Jan;94(1):73-94. doi: 10.7326/0003-4819-94-1-73. Ann Intern Med. 1981. PMID: 7004303 Review.
• Pulmonary sarcoidosis: do cellular and immunochemical lung parameters exist that would separate subgroups of patients for prognosis?

  Reynolds HY. Reynolds HY. Sarcoidosis. 1989 Mar;6(1):1-4. Sarcoidosis. 1989. PMID: 2657919 Review. No abstract available.